Cardiology

Results of the INVESTED trial offer clinicians into the effects of high-dose versus standard-dose influenza vaccines in patients with high-risk cardiovascular disease.

Check out our latest case report from Brady Pregerson, MD, which features a man in his 90s presenting to the ED with fatigue similar to what he had during a diverticular bleed less than 2 weeks prior.

An analysis of data from the Look AHEAD study details the associations between long-term variability of glycemic markers and increased risk of all-cause and cardiovascular mortality.

Diabetic patients are more susceptible to severe COVID-19 outcomes.

Dr. Kausik Ray presents new data on inclisiran and bempedoic acid as cholesterol lowering medications.

New research from the Mayo Clinic is outlining the successes and pitfalls of efforts to improve statin adherence in a comparison of data from the OptumLab Data Warehouse from 2007-2016.

An analysis of data over a 12-year period details the disparities in outcomes following first heart attack among female versus male patients.

Data from an analysis of more than 25k women by a team from Brigham and Women's Hospital and Harvard Medical School suggests greater adherence to a Mediterranean diet was linked to a lower risk of developing diabetes.

The TMIOA Medical Director highlights the best sessions, new topics, and growing discussion around the 18th annual congress.

An analysis of the Look AHEAD study by investigators at Johns Hopkins details associations between long-term variability of glycemic markers and increased risk of all-cause and cardiovascular mortality.

Data from more than 37k patients in the UK Biobank study suggests hypertension in midlife was linked to an increased risk of white matter hyperintensities later in life.

2020 was the year when regulators, clinicians, and patients had no choice but to embrace the concept of wearable monitoring devices. But it’s been a long time coming for the technology class.

A recent analysis of more than 45k patients from Canada suggests women were 20% more likely to die or develop heart failure in the first 5 years after an incident myocardial infarction.

Our annual series is touching on the stories in medicine that occurred during this unforgettable time.

Pediatric patients who initiated insulin pump therapy within 6 months of diagnosis demonstrated better cardiovascular risk profiles than those who delayed treatment.

Check out the latest ImageIQ Quiz from VisualDx. This month's quiz features a 78 y/o man presenting to the ED with recent vomiting after being found in a state of confusion.

Check out the latest case report from Dr. Brady Pregerson, which features a man in his 60s presenting with 16 hours of chest pain.

Largest study of multiple health indicators over time finds widening disparities in health by race, despite increased targeted funding.

With the prevalence of diabetes continuing to grow, Gregory Weiss, MD, reflects on his experience treating patients with diabetes as a cardiologist and how recent advances have impacted cardiology.

Dr. Gregory Weiss details how the expectations of clinicians, and cardiologists specifically, has changed since he began practicing.

An analysis of data from the Women's Health Initiative suggests spending more than 6.5 hours engaged in sedentary behaviors each day was linked to a 42% increase in risk of heart failure in older women.

Dr. Paul D. Thompson tackles the topic of whether use of fenofibrate helps or harms kidney function.

Liquidia Technologies plans on addressing FDA concerns regarding treprostinil.

In this 3-part feature series, an endocrinologist, a cardiologist, and an internist tackle the topic of who should be in charge of treating patients with diabetes and whether the creation of a cardiometabolic specialty is a worthwhile endeavor.

Literature is scarce in identifying and characterizing risk of post-operative diabetes mellitus among patients with pancreatic cystic lesions.

More studies are planned testing the impact of finerenone.

Finerenone could be another option to SGLT2 inhibitors for this patient population.

Researchers present new data from the SUSTAIN 6 and PIONEER 6 trials during the virtual AHA 2020 conference.

AliveCor announced the US FDA has granted 510(k) clearance to Kardia AI V2 algorithm suite.

The rates of ALT normalization maintained in both arms of the 96 week study.